Literature DB >> 2544265

Reduced cerebrospinal fluid B-endorphin levels in Rett syndrome.

A R Genazzani1, M Zappella, A Nalin, Y Hayek, F Facchinetti.   

Abstract

Cerebrospinal fluid (CSF) levels of B-endorphin (B-EP), B-lipotropin (B-LPH) and ACTH were measured in nine girls with Rett syndrome with features of autistic behavior (3.7-12.1 years of age) and in ten children with chronic leukemia (control group). The peptides were measured by radioimmunoassay, either directly in the sample (ACTH) or after Sephadex G-75 column chromatography, in order to eliminate interfering substances (B-LPH and B-EP). The CSF B-EP patient levels (20.8 +/- 13.1 fmol/ml, means +/- SD) were significantly lower than in age-matched controls (69.1 +/- 32.6, P less than 0.01), whereas the B-LPH and ACTH levels were in the control range. No correlations were found between the clinical findings and CSF neuropeptide concentrations. These data demonstrate a decrease in central opiate activity in girls with Rett syndrome.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2544265     DOI: 10.1007/BF00571121

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  20 in total

1.  Pituitary proopiomelanocortin peptides in mental disorders.

Authors:  F Brambilla; F Petraglia; F Facchinetti; M Maggioni; A R Genazzani
Journal:  Prog Brain Res       Date:  1986       Impact factor: 2.453

2.  Rett syndrome--an early catecholamine and indolamine deficient disorder?

Authors:  Y Nomura; M Segawa; M Higurashi
Journal:  Brain Dev       Date:  1985       Impact factor: 1.961

Review 3.  The opiomelanotropinergic neuronal and endocrine systems.

Authors:  T L O'Donohue; D M Dorsa
Journal:  Peptides       Date:  1982 May-Jun       Impact factor: 3.750

4.  Dissociation between CSF and plasma B-endorphin in major depressive disorders: evidence for a different regulation.

Authors:  F Facchinetti; F Petraglia; G Sances; C Garuti; P Tosca; G Nappi; A R Genazzani
Journal:  J Endocrinol Invest       Date:  1986-02       Impact factor: 4.256

5.  Endorphin activity in childhood psychosis. Spinal fluid levels in 24 cases.

Authors:  C Gillberg; L Terenius; G Lönnerholm
Journal:  Arch Gen Psychiatry       Date:  1985-08

6.  Central deficiency of beta-endorphin in alcohol addicts.

Authors:  A R Genazzani; G Nappi; F Facchinetti; G L Mazzella; D Parrini; E Sinforiani; F Petraglia; F Savoldi
Journal:  J Clin Endocrinol Metab       Date:  1982-09       Impact factor: 5.958

7.  CSF beta-endorphin-immunoreactivity in normal, schizophrenic, depressed, manic and anorexic subjects.

Authors:  R H Gerner; B Sharp
Journal:  Brain Res       Date:  1982-04-08       Impact factor: 3.252

8.  beta-Endorphin cerebrospinal fluid decrease in untreated parkinsonian patients.

Authors:  G Nappi; F Petraglia; E Martignoni; F Facchinetti; G Bono; A R Genazzani
Journal:  Neurology       Date:  1985-09       Impact factor: 9.910

9.  ACTH and prednisone in childhood seizure disorders.

Authors:  O C Snead; J W Benton; G J Myers
Journal:  Neurology       Date:  1983-08       Impact factor: 9.910

10.  Plasma endorphins in Rett syndrome: preliminary data.

Authors:  F Facchinetti; M Zappella; A Nalin; F Petraglia; S Bernasconi; A R Genazzani
Journal:  Am J Med Genet Suppl       Date:  1986
View more
  1 in total

Review 1.  μ opioid receptor, social behaviour and autism spectrum disorder: reward matters.

Authors:  Lucie P Pellissier; Jorge Gandía; Thibaut Laboute; Jérôme A J Becker; Julie Le Merrer
Journal:  Br J Pharmacol       Date:  2017-05-04       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.